Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer.
Mori Y, Okimoto Y, Sakai H, Kanda Y, Ohata H, Shiokawa D, Suzuki M, Yoshida H, Ueda H, Sekizuka T, Tamura R, Yamawaki K, Ishiguro T, Mateos RN, Shiraishi Y, Yatabe Y, Hamada A, Yoshihara K, Enomoto T, Okamoto K. Mori Y, et al. Among authors: yamawaki k. Cell Rep Med. 2024 Apr 23:101532. doi: 10.1016/j.xcrm.2024.101532. Online ahead of print. Cell Rep Med. 2024. PMID: 38670097 Free article.
Endometrial Cancer with and without Endometriosis: Clinicopathological Differences.
Minamikawa T, Yachida N, Takahashi K, Saito K, Sekizuka T, Akashi H, Suzuki M, Mori Y, Yamawaki K, Suda K, Tamura R, Adachi S, Yoshihara K. Minamikawa T, et al. Among authors: yamawaki k. Cancers (Basel). 2023 Nov 29;15(23):5635. doi: 10.3390/cancers15235635. Cancers (Basel). 2023. PMID: 38067342 Free PMC article.
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study.
Ikejiri K, Suzuki T, Muto S, Takama H, Yamawaki K, Miyazawa T, Urakawa I, Aoki Y, Otsuki A, Katsuoka F, Kinoshita K, Nangaku M, Akizawa T, Yamamoto M. Ikejiri K, et al. Among authors: yamawaki k. Clin Exp Nephrol. 2024 Mar;28(3):225-234. doi: 10.1007/s10157-023-02427-w. Epub 2023 Nov 14. Clin Exp Nephrol. 2024. PMID: 37962746 Free PMC article. Clinical Trial.
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma.
Akashi H, Yachida N, Ueda H, Yamaguchi M, Yamawaki K, Tamura R, Suda K, Ishiguro T, Adachi S, Nagase Y, Ueda Y, Ueda M, Abiko K, Kagabu M, Baba T, Nakaoka H, Enomoto T, Murai J, Yoshihara K. Akashi H, et al. Among authors: yamawaki k. Mol Cancer Ther. 2024 Jan 3;23(1):106-116. doi: 10.1158/1535-7163.MCT-23-0257. Mol Cancer Ther. 2024. PMID: 37717249
119 results